ATS (ATS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
29 May, 2026Strategic positioning and business overview
Operates as a decentralized automation and technology leader, providing end-to-end automation solutions across diverse industries including life sciences, food & beverage, consumer products, energy, and transportation.
Achieved C$3.0B in adjusted revenues (TTM), with a 5-year adjusted revenue CAGR of 15.7% and adjusted EBITDA margin of 13.9%.
Maintains significant scale with over 7,000 employees, 65+ facilities, and operations in 20+ countries.
Revenue mix is diversified: 51% life sciences, 19% food & beverage, 17% consumer products, 7% transportation, and 6% energy.
North America accounts for 53% of adjusted revenue, followed by Europe (34%) and Asia (13%).
Market focus and revenue breakdown
Focuses on large, attractive end markets with high barriers to entry and regulated environments.
Life sciences is the largest segment with $1,522M in TTM adjusted revenue and $1,077M order backlog.
Other segments include food & beverage ($499M revenue, $260M backlog), consumer products ($553M revenue, $214M backlog), energy ($227M revenue, $278M backlog), and transportation ($170M revenue, $129M backlog).
Business model and operational excellence
The ATS Business Model (ABM) emphasizes performance management, strategic planning, and disciplined goal deployment.
Eight value drivers guide improvement: bookings, revenue, EBIT margin, working capital, on-time delivery, quality, fill rate, and employee turnover.
Standardized performance measurement is applied across all business units.
Latest events from ATS
- Revenue and earnings rose in fiscal 2026, with restructuring driving margin expansion.ATS
Q4 202628 May 2026 - Record financial results, all resolutions passed, and strategic focus on regulated markets.ATS
AGM 202419 May 2026 - Flexible shelf offering supports growth in automation for regulated, high-value markets.ATS
Registration filing27 Apr 2026 - C$2.9B adjusted revenues, 13.8% EBITDA margin, and robust M&A fuel global automation growth.ATS
Investor presentation19 Apr 2026 - Margin expansion, portfolio diversification, and disciplined M&A drive future growth plans.ATS
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q3 revenue up 16.7%, net income surges, and strong backlog supports future growth.ATS
Q3 20264 Feb 2026 - Life sciences and nuclear energy drive growth, with disciplined M&A and resilient market focus.ATS
Raymond James 46th Annual Institutional Investors Conference3 Feb 2026 - Order bookings surged 18.4% as life sciences growth offset transportation softness.ATS
Q1 20252 Feb 2026 - Tripled revenue, tech innovation, and services expansion drive growth in life sciences and EV.ATS
Stifel 2024 Cross Sector Insight Conference31 Jan 2026